|
Ms. Silva is Project Manager, Preclinical Development for Cequent Pharmaceuticals. Prior to joining Cequent, Ms. Silva was Laboratory Manager at Pfizer where she was responsible for pre-approved cardiovascular indicated treatments, dealing primarily with clinical trials and regulatory issues. Prior to her tenure at Pfizer, Ms. Silva was Laboratory Manager at Massachusetts General Hospital (MGH) and Co-Principal Investigator at the Cardiac Catheterization Lab of UMass-Worcester. At Cequent, Ms. Silva is responsible for preclinical development, regulatory issues and strategic development of the clinical platform. Ms. Silva received her undergraduate degree from Clark University and masters from University of Massachusetts Medical Center. | 